| # | Title | Journal | Year | Citations |
|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Autophagy | 2016 | 4,701 |
| 2 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet | Blood | 2010 | 2,963 |
| 3 | Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation | Cancer Cell | 2010 | 2,328 |
| 4 | Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer | Journal of Clinical Oncology | 2005 | 1,867 |
| 5 | Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project | Blood | 2009 | 829 |
| 6 | EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation | Cancer Cell | 2013 | 706 |
| 7 | CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression | Journal of Clinical Investigation | 2011 | 543 |
| 8 | Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project | Lancet Oncology, The | 2009 | 433 |
| 9 | Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology | JAMA - Journal of the American Medical Association | 1999 | 406 |
| 10 | LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer | Oncogene | 2016 | 359 |
| 11 | Significantly Longer Progression-Free Survival With nab-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer | Journal of Clinical Oncology | 2009 | 319 |
| 12 | An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas | Annals of Oncology | 2013 | 318 |
| 13 | Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports | Annals of Oncology | 2011 | 302 |
| 14 | LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer | Cell Reports | 2015 | 291 |
| 15 | Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma | Cancer | 2003 | 285 |
| 16 | The aurora kinases in cell cycle and leukemia | Oncogene | 2015 | 263 |
| 17 | Literacy, self-efficacy, and HIV medication adherence | Patient Education and Counseling | 2007 | 240 |
| 18 | A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma | Annals of Surgical Oncology | 2006 | 225 |
| 19 | Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization | Clinical Gastroenterology and Hepatology | 2013 | 220 |
| 20 | The Continuum of Care: A Paradigm for the Management of Metastatic Colorectal Cancer | Oncologist | 2007 | 218 |
| 21 | ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper | Nature Reviews Clinical Oncology | 2020 | 218 |
| 22 | Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer | JAMA Oncology | 2021 | 217 |
| 23 | Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome | Blood | 2009 | 216 |
| 24 | Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy | Bone Marrow Transplantation | 2007 | 202 |
| 25 | EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis | Cancer Cell | 2016 | 200 |
| 26 | Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing | Genes and Development | 2014 | 193 |
| 27 | Transcription factor networks in erythroid cell and megakaryocyte development | Blood | 2011 | 183 |
| 28 | Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies | Clinical Cancer Research | 2002 | 181 |
| 29 | Minimally Invasive Esophagectomy | Annals of Surgery | 2015 | 178 |
| 30 | MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment | Oncogene | 2015 | 176 |
| 31 | Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients | Bone Marrow Transplantation | 2005 | 168 |
| 32 | Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression | Biochemical Journal | 2012 | 168 |
| 33 | Long‐term responses in patients with recurring or refractory B‐cell non‐Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan | Cancer | 2007 | 164 |
| 34 | Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation | Cell Reports | 2017 | 164 |
| 35 | Apoptosis meets necrosis | Nature | 2011 | 163 |
| 36 | Cancer patient preferences for quality and length of life | Cancer | 2008 | 159 |
| 37 | Germline Allele-Specific Expression of TGFBR1 Confers an Increased Risk of Colorectal Cancer | Science | 2008 | 157 |
| 38 | Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome | Journal of Clinical Investigation | 2012 | 154 |
| 39 | Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways | Journal of Biological Chemistry | 2009 | 152 |
| 40 | Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP–Mediated Expression of HMGA2 | Cancer Research | 2011 | 149 |
| 41 | GATA factor mutations in hematologic disease | Blood | 2017 | 149 |
| 42 | Evaluating the supportive care costs of severe radiochemotherapy‐induced mucositis and pharyngitis | Cancer | 2008 | 147 |
| 43 | Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia | Oncogene | 2014 | 144 |
| 44 | A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era | Blood | 2012 | 138 |
| 45 | Lung Cancer in Women | Journal of Clinical Oncology | 2005 | 137 |
| 46 | Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL | Cell | 2012 | 136 |
| 47 | The evolution of the TOR pathway and its role in cancer | Oncogene | 2013 | 136 |
| 48 | The role of the fat mass and obesity associated gene (FTO) in breast cancer risk | BMC Medical Genetics | 2011 | 132 |
| 49 | Differential Regulation of Membrane Type 1-Matrix Metalloproteinase Activity by ERK 1/2- and p38 MAPK-modulated Tissue Inhibitor of Metalloproteinases 2 Expression Controls Transforming Growth Factor-β1-induced Pericellular Collagenolysis | Journal of Biological Chemistry | 2004 | 130 |
| 50 | Drug-Induced Thrombotic Microangiopathy | Seminars in Thrombosis and Hemostasis | 2005 | 129 |
